Screening for pulmonary arterial hypertension in adults carrying a<i>BMPR2</i>mutation

Abstract

Asymptomatic <i>BMPR2</i> mutation carriers have a significant risk of developing incident PAH. International multicentre studies are needed to confirm that refined multimodal screening programmes with regular follow-up allow early detection of PAH.